Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis

Citation
W. Muller-felber et al., Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis, NEUROMUSC D, 9(8), 1999, pp. 604-607
Citations number
12
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROMUSCULAR DISORDERS
ISSN journal
09608966 → ACNP
Volume
9
Issue
8
Year of publication
1999
Pages
604 - 607
Database
ISI
SICI code
0960-8966(199912)9:8<604:ITORMI>2.0.ZU;2-M
Abstract
Rippling muscle disease is a rare autosomal dominant disorder that may occu r sporadically, In this report two patients presenting with rippling muscle s followed by myasthenia gravis are described. Our first patient developed rippling muscles about 1 month after infection with Yersinia enterocolitica . Two years later myasthenia gravis appeared, Our second patient had a 2-ye ar history of asthma prior to the onset of rippling muscles which preceded the myasthenic symptoms by 4-8 weeks. Acetylcholine receptor and anti-skele tal muscle antibody titers were positive in bath patients, in both patients the rippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with azathioprine. (C) 1999 Elsevier Scie nce B.V, All rights reserved.